Compounds > ig 10
Page last updated: 2024-11-06

ig 10

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

IG 10: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68890
CHEMBL ID2106814
SCHEMBL ID11406912
SCHEMBL ID2111026
SCHEMBL ID2111028
MeSH IDM0132181

Synonyms (25)

Synonym
72788-52-4
ig-10
loxanast [inn]
cis-4-isohexyl-1-methylcyclohexanecarboxylic acid
cis-1-methyl-4-(4-methylpentyl)cyclohexanecarboxylic acid
loxanast
loxanastum [inn-latin]
cyclohexanecarboxylic acid, 1-methyl-4-(4-methylpentyl)-, cis-
1-methyl-4-(4-methylpentyl)cyclohexane-1-carboxylic acid
cyclohexanecarboxylic acid, 1-methyl-4-(4-methylpentyl)-
ig 10
1-methyl-4-isohexylcyclohexanecarboxylic acid
1-methyl-4-(4-methylpentyl)cyclohexanecarboxylic acid
69915-62-4
746ywk1b07 ,
loxanastum
unii-746ywk1b07
CHEMBL2106814
loxanast [jan]
DTXSID00223116
SCHEMBL11406912
SCHEMBL2111026
SCHEMBL2111028
Q27266258
DTXSID801024455
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.17 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index81.24 (26.88)
Search Engine Supply Index2.20 (0.95)

This Compound (50.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
aldosterone
[no description available]		1.961011beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde		human metabolite;
mouse metabolite
trichostatin a
trichostatin A: chelates zinc ion in the active site of histone deacetylases, resulting in preventing histone unpacking so DNA is less available for transcription; do not confuse with TRICHOSANTHIN which is a protein; found in STREPTOMYCES		2.0210antibiotic antifungal agent;
hydroxamic acid;
trichostatin		bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
ovalbumin
Ovalbumin: An albumin obtained from the white of eggs. It is a member of the serpin superfamily.		2.0210
ConditionIndicatedRelationship StrengthStudiesTrials
Cancer of Skin
[description not available]		02.2110
Cutaneous T-Cell Lymphoma
[description not available]		02.2110
Skin Neoplasms
Tumors or cancer of the SKIN.		02.2110
Lymphoma, T-Cell, Cutaneous
A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.		02.2110
Allergy, Food
[description not available]		02.0510
Food Hypersensitivity
Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.		02.0510
Acute Autoimmune Neuropathy
[description not available]		02.0610
Campylobacter Infection
[description not available]		02.0610
Guillain-Barre Syndrome
An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)		02.0610
Ovine Diseases
[description not available]		02.0710
Caprine Diseases
[description not available]		02.0710
Haemonchiasis
Infection with nematodes of the genus HAEMONCHUS, characterized by digestive abnormalities and anemia similar to that from hookworm infestation.		02.0710
Group A Strep Infection
[description not available]		02.0210
Streptococcal Infections
Infections with bacteria of the genus STREPTOCOCCUS.		02.0210
Break-Bone Fever
[description not available]		02.0410
Cane-Cutter Fever
[description not available]		02.0410
Dengue
An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.		02.0410
Leptospirosis
Infections with bacteria of the genus LEPTOSPIRA.		02.0410
Contact Dermatitis
[description not available]		01.9610
Delayed Hypersensitivity
[description not available]		02.3720
Dermatitis, Contact
A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.		01.9610
Erythema
Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.		02.3720